Prostadiag®


An accurate blood-based test

for the screening of prostate cancer 



Current phase: Development


Publications
JP Roperch, G Charbonnier, et al. Multiple highly methylated CpG sites as potential epigenetic markers for the diagnosis of prostate cancer. Clinical Epigenetics (2025) 17:122.https://doi.org/10.1186/s13148-025-01930-z

News